Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells

Molecular Therapy

Volumn 20, Issue 5, 2012, Pages 984-993

  Hirose, Hisaaki ^a   Takeuchi, Toshihide ^a,d   Osakada, Hiroko ^b   Pujals, Sílvia ^a   Katayama, Sayaka ^a   Nakase, Ikuhiko ^a   Kobayashi, Shouhei ^b   Haraguchi, Tokuko ^b,c   Futaki, Shiroh ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HEMAGGLUTININ;

ARTICLE; CELL ADHESION; CELL COMPOSITION; CELL INFILTRATION; CELL MEMBRANE; CELL PERMEABILIZATION; CELL STIMULATION; CONJUGATION; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; INCUBATION TIME; INTERNALIZATION; INTRACELLULAR SIGNALING; MOLECULAR WEIGHT; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN TRANSPORT;

ALEXA;

EID: 84860529568     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.313     Document Type: Article

References (36)

1. Joliot, A and Prochiantz, A (2004). Transduction peptides: from technology to physiology. Nat Cell Biol 6: 189-196. (Pubitemid 38344356)
2. Futaki, S (2008). Membrane permeable peptide vectors: chemistry and functional design for the therapeutic applications. Adv Drug Deliv Rev 60: 447.
3. Futaki, S, Suzuki, T, Ohashi, W, Yagami, T, Tanaka, S, Ueda, K et al. (2001). Argininerich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276: 5836-5840.
4. Rothbard, JB, Garlington, S, Lin, Q, Kirschberg, T, Kreider, E, McGrane, PL et al. (2000). Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med 6: 1253-1257.
5. Viv?, E, Brodin, P and Lebleu, B (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272: 16010-16017. (Pubitemid 27265584)
6. Nakase, I, Takeuchi, T, Tanaka, G and Futaki, S (2008). Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv Drug Deliv Rev 60: 598-607. (Pubitemid 351215576)
7. Wender, PA, Galliher, WC, Goun, EA, Jones, LR and Pillow, TH (2008). The design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Deliv Rev 60: 452-472.
8. Snyder, EL and Dowdy, SF (2005). Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo. Expert Opin Drug Deliv 2: 43-51. (Pubitemid 40123882)
9. Richard, JP, Melikov, K, Vives, E, Ramos, C, Verbeure, B, Gait, MJ et al. (2003). Cellpenetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278: 585-590. (Pubitemid 36043612)
10. Jones, AT (2007). Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J Cell Mol Med 11: 670-684. (Pubitemid 47313298)
11. Nakase, I, Niwa, M, Takeuchi, T, Sonomura, K, Kawabata, N, Koike, Y et al. (2004). Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 10: 1011-1022. (Pubitemid 39625245)
12. Wadia, JS, Stan, RV and Dowdy, SF (2004). Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10: 310-315. (Pubitemid 38667624)
13. Nakase, I, Tadokoro, A, Kawabata, N, Takeuchi, T, Katoh, H, Hiramoto, K et al. (2007). Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry 46: 492-501. (Pubitemid 46105438)
14. Duchardt, F, Fotin-Mleczek, M, Schwarz, H, Fischer, R and Brock, R (2007). A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8: 848-866. (Pubitemid 46971632)
15. Fretz, MM, Penning, NA, Al-Taei, S, Futaki, S, Takeuchi, T, Nakase, I et al. (2007). Temperature-, concentration-and cholesterol-dependent translocation of L-and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells. Biochem J 403: 335-342. (Pubitemid 46596590)
16. Kosuge, M, Takeuchi, T, Nakase, I, Jones, AT and Futaki, S (2008). Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjug Chem 19: 656-664. (Pubitemid 351431397)
17. Koivusalo, M, Welch, C, Hayashi, H, Scott, CC, Kim, M, Alexander, T et al. (2010). Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol 188: 547-563.
18. Matsuzaki, K, Noguch, T, Wakabayashi, M, Ikeda, K, Okada, T, Ohashi, Y et al. (2007). Inhibitors of amyloid beta-protein aggregation mediated by GM1-containing raft-like membranes. Biochim Biophys Acta 1768: 122-130. (Pubitemid 44909079)
19. Simons, K and Ikonen, E (1997). Functional rafts in cell membranes. Nature 387: 569-572. (Pubitemid 27248754)
20. Yamaji, A, Sekizawa, Y, Emoto, K, Sakuraba, H, Inoue, K, Kobayashi, H et al. (1998). Lysenin, a novel sphingomyelin-specific binding protein. J Biol Chem 273: 5300-5306. (Pubitemid 28108696)
21. Haraguchi, T, Kojidani, T, Koujin, T, Shimi, T, Osakada, H, Mori, C et al. (2008). Live cell imaging and electron microscopy reveal dynamic processes of BAF-directed nuclear envelope assembly. J Cell Sci 121: 2540-2554.
22. Katayama, S, Hirose, H, Takayama, K, Nakase, I and Futaki, S (2011). Acylation of octaarginine: Implication to the use of intracellular delivery vectors. J Control Release 149: 29-35.
23. Ryu, DW, Kim, HA, Song, H, Kim, S and Lee, M (2011). Amphiphilic peptides with arginines and valines for the delivery of plasmid DNA. J Cell Biochem 112: 1458-1466.
24. Palm-Apergi, C, Lorents, A, Padari, K, Pooga, M and Hlbrink, M (2009). The membrane repair response masks membrane disturbances caused by cell-penetrating peptide uptake. FASEB J 23: 214-223.
25. McNeil, PL and Steinhardt, RA (2003). Plasma membrane disruption: repair, prevention, adaptation. Annu Rev Cell Dev Biol 19: 697-731. (Pubitemid 37487366)
26. Cai, C, Masumiya, H, Weisleder, N, Matsuda, N, Nishi, M, Hwang, M et al. (2009). MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol 11: 56-64.
27. D'Antuono, C, Ferndez-Tom MC, Sterin-Speziale, N and Bernik, DL (2000). Lipidprotein interactions in rat renal subcellular membranes: a biophysical and biochemical study. Arch Biochem Biophys 382: 39-47.
28. Matsuzaki, K, Nakamura, A, Murase, O, Sugishita, K, Fujii, N and Miyajima, K (1997). Modulation of magainin 2-lipid bilayer interactions by peptide charge. Biochemistry 36: 2104-2111. (Pubitemid 27104701)
29. Tournaviti, S, Hannemann, S, Terjung, S, Kitzing, TM, Stegmayer, C, Ritzerfeld, J et al. (2007). SH4-domain-induced plasma membrane dynamization promotes blebassociated cell motility. J Cell Sci 120: 3820-3829. (Pubitemid 350187363)
30. Ziegler, A, Nervi, P, Drenberger, M and Seelig, J (2005). The cationic cellpenetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44: 138-148. (Pubitemid 40095715)
31. Lamazie, A, Wolf, C, Lambert, O, Chassaing, G, Trugnan, G and Ayala-Sanmartin, J (2008). The homeodomain derived peptide Penetratin induces curvature of fluid membrane domains. PLoS ONE 3: e1938.
32. Afonin, S, Frey, A, Bayerl, S, Fischer, D, Wadhwani, P, Weinkauf, S et al. (2006). The cell-penetrating peptide TAT(48-60) induces a non-lamellar phase in DMPC membranes. Chemphyschem 7: 2134-2142.
33. Mishra, A, Gordon, VD, Yang, L, Coridan, R and Wong, GC (2008). HIV TAT forms pores in membranes by inducing saddle-splay curvature: potential role of bidentate hydrogen bonding. Angew Chem Int Ed Engl 47: 2986-2989.
34. Sakamoto, K, Takino, Y and Ogasawara, K. Methods for controlling membrane permeability of a membrane permeable substance and screening methods for a membrane permeable substance. In: USP appl 2005/0118204, 2 Jun 2005 (JP appl 2003-3774224, 4 Nov 2003).
35. Verdurmen, WP, Thanos, M, Ruttekolk, IR, Gulbins, E and Brock, R (2010). Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake. J Control Release 147: 171-179.
36. Montes, LR, Ruiz-Argllo, MB, Go, FM and Alonso, A (2002). Membrane restructuring via ceramide results in enhanced solute efflux. J Biol Chem 277: 11788-11794. (Pubitemid 34952734)